Significant Modifications of the Salivary Proteome Potentially Associated with Complications of Down Syndrome Revealed by Top-down Proteomics*
暂无分享,去创建一个
Massimo Castagnola | Irene Messana | Tiziana Cabras | Federica Iavarone | Elisabetta Pisano | F. Iavarone | T. Cabras | I. Messana | M. Castagnola | G. Zampino | E. Pisano | Giuseppe Zampino | Caterina Montaldo | Maria Rita Giuca | M. Giuca | C. Montaldo
[1] S. Coburn,et al. Nonprotein Nitrogenous Metabolites in Saliva in Down's Syndrome , 1967, Journal of dental research.
[2] M. Neurath,et al. RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.
[3] I. Nagaoka,et al. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation , 2008, Immunology.
[4] M. Raftery,et al. S100A8 and S100A9-oxidant scavengers in inflammation. , 2013, Free radical biology & medicine.
[5] I. Chernushevich,et al. Total chemical synthesis and chemotactic activity of human S100A12 (EN‐RAGE) , 2001, FEBS letters.
[6] C. Fanali,et al. The Surprising Composition of the Salivary Proteome of Preterm Human Newborn , 2010, Molecular & Cellular Proteomics.
[7] T. Cabras,et al. Different isoforms and post‐translational modifications of human salivary acidic proline‐rich proteins , 2005, Proteomics.
[8] E. Peskind,et al. S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10 , 2009, PloS one.
[9] K. Macleod,et al. Biomarkers of oxidative stress are significantly elevated in Down syndrome. , 1998, Free radical biology & medicine.
[10] V. Prasher,et al. Down's syndrome, dementia, and superoxide dismutase , 1993, British Journal of Psychiatry.
[11] Zhongqi Zhang,et al. A universal algorithm for fast and automated charge state deconvolution of electrospray mass-to-charge ratio spectra , 1998, Journal of the American Society for Mass Spectrometry.
[12] J. Merrick,et al. Salivary LL-37 Secretion in Individuals with Down Syndrome is Normal , 2006, Journal of dental research.
[13] D. E. Deas,et al. Systemic disease and periodontitis: manifestations of neutrophil dysfunction. , 2003, Periodontology 2000.
[14] S. Gorr. Antimicrobial peptides in periodontal innate defense. , 2012, Frontiers of oral biology.
[15] O. Sanal,et al. Neutrophil chemotaxis and periodontal status in Down's syndrome patients. , 1993, The Journal of Nihon University School of Dentistry.
[16] I. Kola,et al. An altered antioxidant balance occurs in Down syndrome fetal organs: implications for the "gene dosage effect" hypothesis. , 2003, Journal of neural transmission. Supplementum.
[17] Sven Cnattingius,et al. Mortality and cancer incidence among individuals with Down syndrome. , 2003, Archives of internal medicine.
[18] M. Sela,et al. Caries levels, Streptococcus mutans counts, salivary pH, and periodontal treatment needs of adult Down syndrome patients. , 1991, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[19] T. Cutress. Composition, flow-rate and pH of mixed and parotid salivas from trisomic 21 and other mentally retarded subjects. , 1972, Archives of oral biology.
[20] T. Cabras,et al. Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. , 2005, European journal of oral sciences.
[21] A. Becker,et al. Stimulated parotid salivary flow rate in patients with Down syndrome. , 2002, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[22] T. Cabras,et al. A Cascade of 24 Histatins (Histatin 3 Fragments) in Human Saliva , 2004, Journal of Biological Chemistry.
[23] F. Halgand,et al. Defining intact protein primary structures from saliva: a step toward the human proteome project. , 2012, Analytical chemistry.
[24] C. Soto,et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis , 2000, Nature Network Boston.
[25] N. Roizen,et al. Down's syndrome , 2003, The Lancet.
[26] 信行 佐々木. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease , 2001 .
[27] W. Siqueira,et al. Salivary Proteome and Its Genetic Polymorphisms , 2007, Annals of the New York Academy of Sciences.
[28] C. Fanali,et al. HPLC-ESI-MS analysis of oral human fluids reveals that gingival crevicular fluid is the main source of oral thymosins beta(4) and beta(10). , 2009, Journal of separation science.
[29] F. Halgand,et al. Confident assignment of intact mass tags to human salivary cystatins using top-down Fourier-transform ion cyclotron resonance mass spectrometry , 2010, Journal of the American Society for Mass Spectrometry.
[30] Massimo Castagnola,et al. Alterations of the Salivary Secretory Peptidome Profile in Children Affected by Type 1 Diabetes , 2010, Molecular & Cellular Proteomics.
[31] D. Linseman,et al. Overexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascade. , 2012, Journal of Alzheimer's disease : JAD.
[32] M. Mann,et al. Mass spectrometry–based proteomics turns quantitative , 2005, Nature chemical biology.
[33] C. Fanali,et al. Detection of Ca2+-binding S100 proteins in human saliva by HPLC-ESI-MS. , 2013, Methods in molecular biology.
[34] P. Berti,et al. Affinity purification and elimination of methionine oxidation in recombinant human cystatin C. , 1997, Protein expression and purification.
[35] Y. Izumi,et al. Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction. , 1989, Journal of periodontology.
[36] Scott A. Puckett,et al. Longitudinal Study on Oral Health in Subjects with Alzheimer's Disease , 1994, Journal of the American Geriatrics Society.
[37] P. Cichoń,et al. Early-onset periodontitis associated with Down's syndrome--clinical interventional study. , 1998, Annals of periodontology.
[38] C. Fanali,et al. Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us? , 2008, Journal of separation science.
[39] D. Butterfield,et al. Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia , 2011, Current gerontology and geriatrics research.
[40] T. Cabras,et al. Identification of the human salivary cystatin complex by the coupling of high‐performance liquid chromatography and ion‐trap mass spectrometry , 2003, Proteomics.
[41] J. Palefsky,et al. Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro , 2007, Journal of leukocyte biology.
[42] C. Fanali,et al. Detection in human saliva of different statherin and P‐B fragments and derivatives , 2006, Proteomics.
[43] D. Friedman,et al. The prevalence of periodontitis and dental caries in a Down's syndrome population. , 1986, Journal of periodontology.
[44] C. Fanali,et al. RP-HPLC-ESI-MS evidenced that salivary cystatin B is detectable in adult human whole saliva mostly as S-modified derivatives: S-Glutathionyl, S-cysteinyl and S-S 2-mer. , 2012, Journal of proteomics.
[45] L. V. Van Eldik,et al. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. , 1994, Biochimica et biophysica acta.
[46] F. Halgand,et al. Micro-heterogeneity of human saliva peptide P-C characterized by high-resolution top-down fourier-transform mass spectrometry , 2010, Journal of the American Society for Mass Spectrometry.
[47] C. Fanali,et al. Age-dependent modifications of the human salivary secretory protein complex. , 2009, Journal of proteome research.
[48] G. Perry,et al. Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosis , 2008, Journal of neurochemistry.